U.S. Hospitality Stock News

NasdaqCM:PCT
NasdaqCM:PCTChemicals

PureCycle Technologies (PCT) Valuation Check After High Profile College Football Recycling Partnership

Event context and why it matters for PureCycle PureCycle Technologies (PCT) is in focus after partnering with Churchill Container and 4ocean to supply reusable Run It Back souvenir cups made with its recycled resin at the College Football Playoff National Championship. The program ties every 20 cups sold to the removal of one pound of ocean trash, giving PureCycle a high profile platform for its recycling technology and putting a clear environmental metric in front of fans and investors. See...
NYSE:MTB
NYSE:MTBBanks

M&T Bank (MTB) Margin Improvement Reinforces Bullish Narratives Despite Slow Growth Forecasts

M&T Bank (MTB) closed out FY 2025 with fourth quarter revenue of US$2.4 billion and basic EPS of US$4.71, alongside net income of US$718 million, framing a year where the trailing 12 month tally reached US$9.2 billion of revenue and US$17.10 in EPS. Over the past few quarters, revenue has moved from US$2.2 billion in Q4 2024 to US$2.4 billion in Q4 2025, while quarterly EPS increased from US$3.88 to US$4.71, supported by higher net income. This sets up a results season in which investors are...
NasdaqGM:RAPP
NasdaqGM:RAPPPharmaceuticals

Rapport Therapeutics (RAPP) Is Down 7.4% After Advancing RAP-219 Toward Phase 3 In Epilepsy

In early January 2026, Rapport Therapeutics announced past and planned advances across its clinical pipeline, including preparing a Phase 3 program for RAP-219 in focal onset seizures, expanding into primary generalized tonic-clonic seizures, and resuming its Phase 2 diabetic peripheral neuropathic pain trial after the FDA lifted a clinical hold. A key insight is that Rapport is concentrating resources on programs it believes can meaningfully address unmet neurological needs while supporting...
OTCPK:NODB
OTCPK:NODBBanks

North Dallas Bank & Trust (OTCPK:NODB) Margin Rebound Challenges Longstanding Bearish Narratives

North Dallas Bank & Trust (NODB) just wrapped up FY 2025 with fourth quarter total revenue of US$12.9 million and basic EPS of US$1.19, capping a trailing twelve month stretch that sums to US$48.0 million in revenue and EPS of US$3.35. Over the past few quarters, revenue has moved from US$9.8 million in Q3 2024 to US$12.9 million in Q4 2025. Quarterly EPS has ranged from US$0.20 in Q3 2024 to US$1.19 most recently, alongside reported profit growth of 166.6% and a net profit margin that...
NYSE:PRKS
NYSE:PRKSHospitality

How Investors Are Reacting To United Parks & Resorts (PRKS) 2026 SeaWorld Concert-Centered Guest Experience

United Parks & Resorts recently announced that SeaWorld returned in early 2026 with an expanded coast-to-coast live music series, offering full-length concerts by artists such as Flo Rida, Boyz II Men, and The Beach Boys in Orlando, San Diego, and San Antonio at no extra cost beyond park admission. This move places live entertainment at the center of the guest experience and is designed to deepen Annual Pass value by giving members flexible, season-long access to multiple concerts across...
NYSE:SEM
NYSE:SEMHealthcare

Does Select Medical’s Medicare Lobbying Push Change The Bull Case For Select Medical Holdings (SEM)?

In Q4 2025, Select Medical Holdings Corporation disclosed spending US$630,000 on lobbying related to regulations for long-term acute care hospitals, inpatient rehabilitation facilities, and outpatient rehabilitation clinics, with a particular focus on Medicare payment issues, while institutional investors showed mixed positioning and analysts recently issued positive ratings. This combination of targeted policy engagement and favorable analyst sentiment highlights how regulatory influence...
NYSE:ICL
NYSE:ICLChemicals

Earnings Upgrade And Higher Forecasts Might Change The Case For Investing In ICL Group (ICL)

ICL Group was recently upgraded by Zacks to a Rank #2 (Buy) after analysts raised their earnings estimates, with the consensus forecast climbing 11.1% over the past three months, signaling a more favorable earnings outlook than previously expected. This upward revision in earnings expectations suggests analysts see improving profit potential for ICL’s specialty minerals and chemicals portfolio, which could influence how investors view the company’s longer-term business prospects and risk...
NYSE:DAR
NYSE:DARFood

Is Darling Ingredients (DAR) Pricing Reflect A 40% Five Year Slide And Rich P/E Ratio

If you are wondering whether Darling Ingredients is reasonably priced or offering a margin of safety right now, this article will walk through what the current share price might be implying about its value. The stock recently closed at US$39.57, with returns of 1.3% over 7 days, 14.4% over 30 days, 5.1% year to date, 8.0% over 1 year, and a 39.7% and 40.7% decline over 3 and 5 years respectively. Taken together, these figures give mixed signals about how the market has been treating the...
NYSE:STUB
NYSE:STUBEntertainment

A Look At StubHub Holdings (STUB) Valuation As Class Action Lawsuits Spotlight IPO Cash Flow Disclosures

StubHub Holdings (STUB) is back in focus as multiple securities class action lawsuits over its 2025 IPO disclosures approach a January 23 lead plaintiff deadline, keeping legal and cash flow questions front and center for shareholders. See our latest analysis for StubHub Holdings. Recent trading reflects elevated uncertainty, with a 7 day share price return of 25.29% and a 30 day gain of 14.37% partly offsetting a 90 day share price return of negative 6.71%. The stock is at $16.0 with year to...
NasdaqGS:INDV
NasdaqGS:INDVPharmaceuticals

Assessing Indivior (NasdaqGS:INDV) Valuation After Recent Share Price Swings And DCF Upside Potential

Event context and recent stock performance Indivior (INDV) has been on investors’ radar after recent share price swings, with the stock showing a 1 day return of 1.05% and a 7 day decline of 8.18%. Over the past month the share price return is a 9.49% decline, contrasting with a 32.92% gain over the past 3 months. This may prompt investors to reassess how current pricing lines up with Indivior’s fundamentals. See our latest analysis for Indivior. At a share price of US$32.54, Indivior’s...
NYSE:ARX
NYSE:ARXInsurance

Assessing Accelerant Holdings (ARX) Valuation After Recent Share Price Momentum Cools

Event context for Accelerant Holdings Accelerant Holdings (ARX) has drawn investor attention after recent share price moves, with the stock showing a negative 1 day return of 2.1% and a negative 7 day return of 4.8%. Over the past month the stock posted a negative return of 4.5%. Over the past 3 months it shows a 16.4% gain, setting up a contrast that raises questions about how investors are weighing its growing revenue and current net loss. See our latest analysis for Accelerant Holdings. At...
NYSE:USAC
NYSE:USACEnergy Services

Did USA Compression Partners' (USAC) Steady Payout and New Financing Just Reframe Its Income Story?

USA Compression Partners, LP recently declared a fourth-quarter 2025 cash distribution of US$0.525 per common unit (US$2.10 annualized), payable on February 6, 2026 to unitholders of record as of January 26, 2026, and scheduled its fourth-quarter earnings release and conference call for February 17, 2026. Together with new financing agreements linked to a recent acquisition, these announcements highlight USA Compression Partners’ focus on supporting its distribution while reinforcing its...
NasdaqGS:OUST
NasdaqGS:OUSTElectronic

Is Ouster’s (OUST) Needham Pitch Revealing a New Capital Allocation Playbook for Investors?

Ouster recently presented at the 28th Annual Needham Growth Conference on January 15, 2026, at The Lotte New York Palace Hotel in New York, where CEO Angus Pacala, Senior VP of Strategic Finance & Treasurer Chen Geng, and CFO Kenneth P. Gianella addressed attendees. This high-profile conference appearance gave Ouster’s leadership a platform to communicate its roadmap and capital allocation priorities directly to institutional investors and analysts. We’ll now examine how Ouster’s Needham...
NasdaqGM:XNCR
NasdaqGM:XNCRBiotechs

A Look At Xencor (XNCR) Valuation After New XmAb819 Renal Cancer Data And Pipeline Milestone Update

Xencor (XNCR) recently outlined 2026 priorities for its XmAb platform, highlighting early clinical data for renal cell carcinoma candidate XmAb819 and setting out timelines for multiple oncology and autoimmune milestones that could influence investor expectations. See our latest analysis for Xencor. Despite the fresh 2026 pipeline update, Xencor’s recent share price momentum has been weak, with a 30 day share price return of a 19.05% decline and a 1 year total shareholder return of a 33.52%...
NYSEAM:ROLR
NYSEAM:ROLRHospitality

Why High Roller Technologies (ROLR) Is Up 541.8% After Crypto.com U.S. Prediction Markets Deal Announcement

In mid-January 2026, High Roller Technologies, Inc. announced a binding Letter of Intent with Crypto.com | Derivatives North America to power a regulated, event-based prediction markets product in the United States, alongside multiple non-binding marketing LOIs with social-first sports media platforms to support its planned launch. A distinctive aspect of this move is High Roller’s effort to pair regulated prediction-market infrastructure with billion-scale social media reach from partners...
NYSE:HE
NYSE:HEElectric Utilities

A Look At Hawaiian Electric Industries (HE) Valuation As Wildfire Settlements And New Legislation Reset Risk Profile

Hawaiian Electric Industries (HE) is back in focus after reaching preliminary agreements to settle eight shareholder lawsuits tied to wildfire risk disclosures, funded by US$100 million in insurance proceeds and accompanied by new Hawaii wildfire legislation. See our latest analysis for Hawaiian Electric Industries. The wildfire settlement progress and new Hawaii legislation arrive after a sharp rebound in sentiment, with a 20.72% 1 month share price return and a 58.10% 1 year total...
NasdaqGS:WAFD
NasdaqGS:WAFDBanks

WaFd (WAFD) Net Interest Margin Of 2.7% Reinforces Bullish Profitability Narratives

WaFd (WAFD) opened fiscal Q1 2026 with total revenue of US$187.9 million and basic EPS of US$0.79, while trailing twelve month revenue stood at US$734.5 million and EPS at US$2.89, giving investors a clear view of both the latest quarter and the broader earnings run rate. Over recent quarters, the bank has seen revenue move from US$171.1 million in Q1 2025 to US$187.9 million in Q1 2026, with quarterly EPS shifting from US$0.54 to US$0.79 across the same period, setting up this result against...
NYSE:EPAC
NYSE:EPACMachinery

Could William Blair’s New Coverage of Enerpac (EPAC) Reframe Expectations Around Its Earnings Power?

Earlier this month, Enerpac Tool Group Corp. presented at CJS Securities’ 26th Annual “New Ideas for the New Year” Investor Conference on January 14, 2026, and has since attracted fresh analyst attention. William Blair’s initiation of coverage with a “Market Perform” rating adds another professional viewpoint to existing research, potentially broadening institutional interest and debate around Enerpac’s prospects. Next, we’ll examine how William Blair’s new coverage could influence Enerpac...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Is Nutanix (NTNX) Attractively Priced After The Recent Share Price Slump

If you are wondering whether Nutanix is attractively priced or just feels cheap after a rough patch, you are exactly who this breakdown is for. The stock recently closed at US$45.74, with returns of a 14.5% decline over 7 days, 8.9% decline over 30 days, 9.6% decline year to date, 29.8% decline over 1 year, but 70.7% and 36.5% gains over 3 and 5 years respectively. This points to mixed sentiment and changing expectations around the company. Recent attention on Nutanix has focused on its...
NasdaqGS:WABC
NasdaqGS:WABCBanks

Westamerica Bancorporation (WABC) High Net Margin Challenges Bearish Earnings Narratives

Westamerica Bancorporation (WABC) has wrapped up FY 2025 with fourth quarter revenue of US$63.3 million and basic EPS of US$1.12, alongside net income of US$27.8 million, providing a clear snapshot of its latest run rate. The bank has seen quarterly revenue shift from US$73.9 million in Q3 2024 to US$63.3 million in Q4 2025, with basic EPS moving from US$1.31 to US$1.12 over the same stretch. Trailing twelve month revenue for Q4 2025 is US$258.4 million and EPS is US$4.52. In that context,...
NasdaqGS:JCAP
NasdaqGS:JCAPConsumer Finance

Assessing Jefferson Capital (JCAP) Valuation After Recent Mixed Short-Term Share Price Moves

What Jefferson Capital’s recent trading signals tell you Recent trading in Jefferson Capital (JCAP) has drawn attention after a mixed pattern of short term declines alongside gains over the past month and past 3 months, prompting investors to reassess how its fundamentals line up with sentiment. See our latest analysis for Jefferson Capital. With the share price at $22.55, Jefferson Capital’s recent 1 day and 7 day share price declines contrast with a stronger 30 day and especially 90 day...
NasdaqGM:RILY
NasdaqGM:RILYCapital Markets

Assessing BRC Group Holdings (RILY) Valuation After Earnings Turnaround And Nasdaq Compliance Return

BRC Group Holdings (RILY) is back in focus after reporting third quarter 2025 earnings that shifted from a net loss a year ago to substantial net income, along with lower net debt and restored Nasdaq compliance. See our latest analysis for BRC Group Holdings. That earnings swing and return to Nasdaq compliance have gone hand in hand with sharp share price moves, including a 98% 1 month share price return and a 71.62% year to date share price return, even as the 3 year total shareholder return...